Join the Shift Toward Non-Opioid Pain Care

The provider organizations that are out in front of the non opioid shift have a few things in common. They have a defined chronic pain population they are trying to serve better. They have a clinical leader who has decided that adding non pharmacologic options is a strategic priority, not a side project. They have an operational appetite for adding a new modality without rebuilding the rest of the workflow. The bioelectric category is a natural fit for organizations in that posture, and the Electrome platform is built to support them.

What the program looks like

A provider program with the platform looks like this. The clinical team identifies the patient cohort. The platform supplies the wearable, the protocol, the patient onboarding, and the workspace the clinician uses to monitor the cohort. RTM compliant documentation is generated as patients use the device. Outcomes are tracked continuously and surfaced in a way that supports both clinical decisions and program reporting. The program is operationally light because the platform absorbs the operational weight.

What the team does and does not have to do

The clinical team does what only they can do. Identify the patients. Set the care plan. Have the patient conversation. Adjust based on what the data and the patient report. The team does not have to build the data backbone, the documentation flow, the patient onboarding, the consent workflow, the educational content, or the regulatory language. Those are the parts the platform is responsible for, and they are the parts that have historically slowed down provider adoption of new modalities.

How to start

Starting is intentionally lightweight. A short conversation with the platform team to size the cohort and define the program parameters. A short clinical training, because the device is simple and the workspace is built around the existing workflow. A staged enrollment of the initial cohort. Within a few weeks the program is producing data. Within a few months the program is producing the kind of outcomes evidence that internal stakeholders, payers, and patients can all read.

What this is not

This is not a research collaboration, although research collaborations are possible separately. It is a clinical program built on an FDA cleared therapy and a supporting platform. The framing is meant to be clear so that internal champions can describe the program accurately to their leadership.

The longer view

The longer view is that the non opioid shift is going to be the defining structural change in chronic pain care over the next decade, and the provider organizations that build their programs early are going to set the patterns the rest of the field follows. The Electrome platform is built to support those organizations now, and to keep getting better as the population those programs serve grows.